Robert Foster, MD
Interventional Cardiology · Birmingham, ALNPI 1720163140
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $57,125 of the $89,751 with a category attached, or 63.6%. Medtronic accounts for 68.0% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2019 at $28,354 and has fallen 99.2% since, to $219 in 2025. Among interventional cardiology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 251 payments — averaging $357.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$61K
- Endologix LLC$23K
- Philips North America LLC$2K
- Silk Road Medical, Inc.$999
- Novartis$423
- Boston Scientific$335
- plus $1K from 23 others
Across 46 payments — averaging $11,521 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Veryan Medical Incorporated$523K
- Medtronic$6K
- Amgen$1K
What the payments were for
- Consulting fees$23,54526%
- Speaking & faculty fees$57,12564%
- Travel & lodging$4,3485%
- Food & beverage$4,7335%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 95 | $61,066 |
| Endologix LLC | 34 | $23,318 |
| Philips North America LLC | 4 | $2,220 |
| Silk Road Medical, Inc. | 9 | $999 |
| Novartis | 32 | $423 |
| Boston Scientific | 13 | $335 |
| Biocompatibles, Inc. | 9 | $152 |
| Johnson & Johnson | 10 | $152 |
| Pfizer | 10 | $148 |
| Veryan Medical Incorporated | 2 | $122 |
| E.r. Squibb & Sons, L.L.C. | 1 | $122 |
| Asahi Intecc USA, Inc. | 1 | $94 |
| Angiodynamics, Inc. | 2 | $84 |
| Astellas Pharma US Inc | 4 | $73 |
| Merck | 3 | $69 |
| Amgen | 4 | $54 |
| Abbott | 2 | $42 |
| Amarin Pharma, Inc. | 3 | $38 |
| Inari Medical, Inc. | 1 | $37 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Siemens Medical Solutions USA, Inc. | 1 | $29 |
| Boehringer Ingelheim | 2 | $25 |
| Genentech USA, Inc. | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| Avanos Medical | 1 | $16 |
| Dompe US, Inc. | 1 | $16 |
| Z-medica, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaSeal$46,766
- ClosureFast$12,219
- AFX$9,900
- Alto Abdominal Stent Graft System$9,600
- Ovation$2,700
- AFX2 Bifurcated Endograft System$2,700
- IGT D Peripheral$2,145
- ENROUTE Transcarotid Neuroprotection System$842
- ENROUTE Transcarotid Stent System$722
- ENHANCE Transcarotid Peripheral Access Kit$722
- ENROUTE 0.014 Guidewire$722
- CAMZYOS$122
- ENROUTE Transcarotid Stent$119
How this compares
$89,751 in reported general payments places this provider in the 95th percentile of 109 interventional cardiology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 12 | $2,433 |
| Metoprolol Succinate | 35 | $727 |
| Isosorbide Mononitrate | 14 | $639 |
| Atorvastatin Calcium | 26 | $387 |
| Ranolazine ErRanolazine | 12 | $309 |
| ClopidogrelClopidogrel Bisulfate | 16 | $214 |
| Furosemide | 20 | $110 |
| Metoprolol Tartrate | 13 | $94 |
| Amlodipine Besylate | 15 | $28 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Birmingham
- Gary RoubinBirmingham$157K
- Hasan GuvenBirmingham$86K
- Abdullah MahmoodBirmingham$61K
- Ali EbrahimiBirmingham$55K
- Jacob TownsendBirmingham$52K
- Kamran AliBirmingham$47K
- Mouhamed SabouniBirmingham$44K
- David SchultzBirmingham$19K
- Tushar MishraBirmingham$17K
- Arka ChatterjeeBirmingham$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.